Canara Robeco Emerging Equities Fund: Striving to Deliver Consistent Returns

Dec 03, 2020

Listen to Canara Robeco Emerging Equities Fund: Striving to Deliver Consistent Returns

00:00 00:00

The mid and small cap index has had a good run in the last one year, outperforming the large cap index with a significant margin. This was despite the fact that the pandemic crisis affected smaller businesses the most. The small and mid cap segment may continue to do well backed by economic revival and government stimulus.

But one needs to remain cautious about the volatility in the segment as compared to large caps. It will be best to have reasonable exposure across market caps.

Large and mid cap funds are a separate set of multi-cap strategy that gives you the opportunity to diversify your investment predominantly across stocks of large and mid-sized companies with some allocation to small caps.

Canara Robeco Emerging Equities Fund (CREEF) is one of the leading players in the large and mid cap funds category that has a superior performance track record of rewarding investors.

Graph 1: Growth of Rs 10,000 if invested in Canara Robeco Emerging Equities Fund 5 years ago

Originally a mid and small cap biased fund, CREEF underwent a change in mandate to become large and mid cap fund. The fund has managed to put up a decent performance over complete market cycles by participating in the recovery phases and upside market rallies. Over the last five years, CREEF has generated returns at 14.3% CAGR in comparison to 12.1% CAGR generated by its benchmark Nifty LargeMidcap 250 – TRI index. The fund has thus outpaced the benchmark by a noticeable margin of around 2 percentage points. Much of the outperformance over the index in the last 5 years has been registered during the mid and small cap rally seen in 2016-2017, when its portfolio was biased towards mid and small caps; and CREEF has stood strong in the recent corrective phase.

Graph 1
Data as on December 02, 2020
(Source: ACE MF)
 

Table: Canara Robeco Emerging Equities Fund's performance vis-à-vis category peers

Scheme Name Corpus (Cr.) 1 Year (%) 2 Year (%) 3 Year (%) 5 Year (%) 7 Year (%) Std Dev Sharpe
Mirae Asset Emerging Bluechip Fund 11,929 18.98 17.58 10.96 17.33 25.81 22.84 0.085
Edelweiss Large & Mid Cap Fund 528 14.54 12.85 9.16 12.07 15.32 20.58 0.063
Kotak Equity Opp Fund 3,885 15.28 14.89 9.00 13.54 17.24 21.50 0.052
Tata Large & Mid Cap Fund 1,666 11.81 13.24 8.88 11.27 15.91 21.31 0.052
Canara Rob Emerg Equities Fund 6,126 21.35 15.23 8.48 14.24 24.63 22.23 0.054
Invesco India Growth Opp Fund 3,018 8.42 10.28 8.41 12.98 16.50 20.51 0.051
Sundaram Large and Mid Cap Fund 1,247 4.53 8.55 7.37 11.82 16.26 22.83 0.038
SBI Large & Midcap Fund 2,912 11.09 9.87 6.18 10.54 15.79 22.38 0.021
Principal Emerging Bluechip Fund 2,120 18.95 12.80 6.10 14.14 21.62 22.50 0.019
DSP Equity Opportunities Fund 4,869 10.74 12.16 5.99 12.45 16.40 22.52 0.019
Nifty LargeMidcap 250 Index - TRI 15.72 11.05 6.84 12.11 15.94 23.20 0.031
Returns are point to point and in %, calculated using Direct Plan - Growth option. Those depicted over 1-Yr are compounded annualised.
Data as on December 02, 2020
(Source: ACE MF)
*Please note, this table only represents the best performing funds based solely on past returns and is NOT a recommendation. Mutual Fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not an indicator for future returns. The percentage returns shown are only for indicative purposes.

CREEF has managed to maintain substantial lead over most of its category peers across various time periods. The fund has outperformed its benchmark Nifty LargeMidcap 250 - TRI by a noticeable margin across both short term and long term returns basis. Over longer time periods, CREEF easily ranks among the top schemes, and makes it to the list of prime contenders.

The volatility registered by the fund is nearly in line with the category peers though slightly lower than the benchmark. The fund has managed to generate sound returns to compensate investors for the risk taken. Its Sharpe ratio, a measure of risk-adjusted returns, is among the best in the large and mid-cap funds category.

Investment strategy of Canara Robeco Emerging Equities Fund

Being a large and mid cap fund, CREEF is mandated to invest a minimum 35% of its assets in large-caps, with a simultaneous investment of at least 35% in mid-caps. The fund currently has a balanced exposure across both large caps and midcaps and holds a well-diversified portfolio of 55 to 65 stocks, with focus on quality, growth, and valuation.

While evaluating companies, the fund managers emphasise on its qualitative features, management and governance. They also look at quantitative parameters by analyzing the balance sheet and use valuation to determine the weight, i.e. underweight / overweight position in stocks. The core focus of the fund is on cash flow generating businesses. For the purpose of investment, the fund focuses on companies with low P/E ratio (as compared to the industry P/E), consistent growth potential, operating in niche businesses with high and increasing profit margin, huge untapped market potential, research driven companies, scope for value added services, scope for increasing PE to Growth and so on.

CREEF uses a mix of top-down and bottom-up approach to pick high growth stocks from the list of eligiblecompanies in the large and mid-cap space and makes well use of diversification to manage downside risk. The fund has a reasonable turnover ratio of around 60%.

Graph 2: Top portfolio holdings in Canara Robeco Emerging Equities Fund

Graph 2 Graph 2
Holding in (%) as on October 31, 2020
(Source: ACE MF)

As on October 31, 2020, CREEF held a well-diversified portfolio of 56 stocks diversified across market caps and sectors. The fund held its top exposure of 5.7% in HDFC Bank, followed by 5.1% in Infosys, 4.9% in ICICI Bank, 4.8% in Reliance Industries, and around 3.2% each in Bajaj Finance and Axis Bank. Ipca Laboratories, Voltas, Cholamandalam Investment & Finance Company, and Atul, were the other names in its top holdings. The top 10 holdings in the fund's portfolio together account for about 36.2% of the total assets.

CREEF has benefitted immensely from its holdings in Ipca Laboratories, Reliance Industries, Divis Laboratories, Infosys, NavinFlourine International, IRCTC, L&T Infotech, and Balkrishna Industries, which have turned out to be major contributors to its returns in the last one year. Moreover, other mid cap names like Atul, Gujarat Gas, Jubilant FoodWorks, Synegene International, etc. have helped the fund generate significant alpha for its investors.

CREEF's portfolio is currently skewed towards Financial Services, with Banks carrying around 16.8% weightage in the portfolio, with another 10.4% in Finance stocks. The fund has significant exposure in Consumption, Infotech, Pharma, and Chemicals stocks with an allocation of in the range of 5.10%. Engineering, Petroleum, Consumer Durables, Cement,and Auto ancillaries are among the other prominent sectors in the fund's portfolio. Notably, around 77% of its portfolio is diversified across top 10 sector holdings.

Suitability

CREEF has delivered promising returns over longer time periods and has proven its ability to generate decent risk-adjusted returns for its investors. In the recent corrective phase, the performance of the fund has been satisfactory, where it has managed to restrict losses reasonably well and maintain the gains made in the prior bull phase. CREEF maintains a well-diversified portfolio of stocks spread across sectors and balanced across large cap and mid cap segment to mitigate risk. However, higher weightage to few sectors such as banking and financial may temporarily increase volatility if the sector comes under pressure for any reason. This makes the fund suitable for aggressive investors having high risk appetite and an investment horizon of more than five years.

 

Warm Regards,
Divya Grover
Research Analyst

 

PS: If you wish to select worthy mutual fund schemes, subscribe to PersonalFN's unbiased premium research service, FundSelect. Each fund recommended under FundSelect goes through our stringent process, where funds are tested on both quantitative as well as qualitative parameters.

Every month, PersonalFN's FundSelect service will provide you with insightful and practical guidance on equity mutual funds and debt schemes - the ones to Buy, Hold, or Sell.

And on the occasion of 20 years of our unbiased research service, we bring to you this Special Anniversary Offer. Subscribe now!

Note: This write up is for information purpose and does not constitute any kind of investment advice or a recommendation to Buy / Hold / Sell a fund. Returns mentioned herein are in no way a guarantee or promise of future returns. As an investor, you need to pick the right fund to meet your financial goals. If you are not sure about your risk appetite, do consult your investment consultant/advisor. Mutual Fund Investments are subject to market risks, read all scheme related documents carefully.

 

Join Now: PersonalFN is now on Telegram. Join FREE Today to get ‘Daily Wealth Letter’ and Exclusive Updates on Mutual Funds

 

DISCLOSURE AS PER SECURITIES AND EXCHANGE BOARD OF INDIA (RESEARCH ANALYSTS) REGULATIONS, 2014

About the Company including business activity

Quantum Information Services Private Limited (QIS) was incorporated on December 19, 1989.

QIS was promoted by Mr Ajit Dayal with an objective of providing value-based information/views on news related to equity markets, the economy in general, sector analysis, budget review and various personal products and investments options available to the Public. It was the first company to start equity research on an institutional level.

'PersonalFN' is a service brand of QIS and was started in the year 1999. In 1999, the Company registered the Domain name www.personalfn.com for providing information on mutual funds and personal financial planning, financial markets in general, etc. and services related to financial planning and research in various financial instruments including mutual funds, insurance and fixed income products to customers. It offers asset allocation and researched investment recommendations through its financial planning services.

Quantum Information Services Private Limited (QIS) is registered as Investment Adviser under SEBI (Investment Adviser) Regulations, 2013 and having Registration No.: INA000000680. In terms of the second proviso to Regulation 3 (1) of SEBI (Research Analysts) Regulations, 2014 the Company is not required to obtain Certificate of registration from SEBI.

Disciplinary history

There are no outstanding litigations against the Company, its subsidiaries and its Directors.

Terms and condition on which its offer research report

For the terms and condition for research report click here.

Details of associates

  1. Money Simplified Services Private Limited;

  2. PersonalFN Insurance Services India Private Limited;

  3. Equitymaster Agora Research Private Limited;

  4. Common Sense Living Private Limited;

  5. Quantum Advisors Private Limited;

  6. Quantum Asset Management Company Private Limited;

  7. HelpYourNGO.com India Private Limited;

  8. HelpYourNGO Foundation;

  9. Natural Streets for Performing Arts Foundation;

  10. Primary Real Estate Advisors Private Limited;

  11. HYNGO India Private Limited;

  12. Suresh Lulla;

  13. I V Subramaniam.

Disclosure with regard to ownership and material conflicts of interest
  1. ‘subject company’ is a scheme on which a buy/sell/hold view or target price is given/changed in this Research Report;

  2. Neither QIS, it's Associates, Research Analyst or his/her relative have any financial interest in the subject Company; except for one of the Research Analysts holding units of Canara Robeco Emerging Equities Fund;

  3. Neither QIS, it's Associates, Research Analyst or his/her relative have actual/beneficial ownership of one per cent or more securities of the subject Company, at the end of the month immediately preceding the date of publication of the research report;

  4. Neither QIS, it's Associates, Research Analyst or his/her relative has any other material conflict of interest at the time of publication of the research report except that QIS (PersonalFN) is, as per SEBI (Mutual Funds) Regulations 1996, an associate / group Company of Quantum Asset Management Company Private Limited and Trustees and Sponsor of Quantum Mutual Fund (QMF) and to that extent there may be conflict of interest while recommending any schemes of QMF. However, any such recommendation or reference made is based on the standard evaluation and selection process, which applies uniformly for all Mutual Fund Schemes. The payment of commission (upfront / annualized & trail), if any, for any Schemes by QMF to QIS (PersonalFN) is also at arm's length and as per prevailing market practices.

Disclosure with regard to receipt of Compensation
 
  1. Neither QIS nor it's Associates have received any compensation from the subject Company in the past twelve months;

  2. Neither QIS nor it's Associates have managed or co-managed public offering of securities for the subject Company;

  3. Neither QIS nor it's Associates have received any compensation for investment banking or merchant banking or brokerage services from the subject Company;

  4. Neither QIS nor it's Associates have received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months.

  5. Neither QIS nor it's Associates have received any compensation or other benefits from the subject Company or third party in connection with the research report

General disclosure
  1. The Research Analyst has not served as an officer, director or employee of the subject Company.

  2. QIS or the Research Analyst has not been engaged in market making activity for the subject Company.

Click here to read PersonalFN's Mutual Fund Rating Methodology

Subject Company means Mutual Fund Schemes

Quantum Information Services Private Limited CIN: U65990MH1989PTC054667 Regd. & Corp. Office: 103, Regent Chambers, 1st Floor, Nariman Point, Mumbai - 400 021

Email:info@personalfn.com Website: www.personalfn.com Tel.: 022 61361200 Fax.: 022 61361222 SEBI-registered Investment Adviser. Registration No. INA000000680, SEBI (Investment Advisers) Regulation, 2013

PersonalFN' requests your view! Post a comment on "Canara Robeco Emerging Equities Fund: Striving to Deliver Consistent Returns". Click here!

Most Related Articles

JM Flexi Cap Fund: Rewarding Investors with Robust Returns JM Flexi Cap Fund is a lesser-known Flexi Cap Fund that has turned out to be a category outperformer by delivering superior gains in recent years. 

Apr 10, 2025

HDFC Large Cap Fund: Benefitting from Fundamentally Strong Large-cap Stocks HDFC Large Cap Fund is a popular Large Cap Fund known for its strong performance during bull markets.

Mar 27, 2025

Tata Small Cap Fund: Targeting Growth at Reasonable Valuations Tata Small Cap Fund is a growth-oriented scheme in the Small Cap Fund category that has exhibited a noteworthy track record since its inception.

Mar 20, 2025

SBI Long Term Equity Fund: Tapping Opportunities through Value-conscious Approach SBI Long Term Equity Fund is among the oldest and most well-known schemes in the ELSS category, that has effectively tapped into the recent broad-based market rally. 

Mar 06, 2025

HDFC Focused 30 Fund: Excelling through High Conviction Stocks HDFC Focused 30 Fund is a high-conviction Focused Fund that has demonstrated a strong rebound after a period of subdued performance, through its high conviction bets  

Feb 27, 2025

Most Popular

Manufacturing Mutual Funds Shine. Are they Worthy of Your Investment Portfolio?Currently contributing around 17% to the GDP, the manufacturing sector is expected to grow to 21% in the next 6-7 years.

May 06, 2024

6 Equity Mutual Funds to Benefit from India’s Defence SectorThe potential to benefit by sensibly taking exposure to defence sector stocks is huge!

Apr 17, 2024

Top 5 Mutual Funds with High Exposure to EV RevolutionThis article will evaluate the top mutual funds to invest in 2024 that have a high allocation to EV stocks.

Feb 06, 2024

Top Manufacturing Mutual Funds in India to Boost Your PortfolioThis article will evaluate the top mutual funds to invest in 2024 that have a high allocation to Manufacturing stocks.

Oct 28, 2024

HDFC Mutual Fund launches HDFC Manufacturing FundHDFC Mutual Fund launches HDFC Manufacturing Fund

May 08, 2024